Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Novel therapeutic strategies to target leukemic cells that hijack compartmentalized continuous hematopoietic stem cell niches
Authors:ID Hira, Vashendriya V. V. (Author)
ID Noorden, Cornelis J. F. van (Author)
ID Carraway, Hetty E. (Author)
ID Maciejewski, Jaroslaw P. (Author)
ID Molenaar, Remco J. (Author)
Files:URL URL - Source URL, visit https://www.sciencedirect.com/science/article/pii/S0304419X1630124X?via%3Dihub
 
.pdf PDF - Presentation file, download (1,69 MB)
MD5: EF8B282F389F5BC262619AD3144429D6
 
URL URL - Source URL, visit https://doi.org/10.1016/j.bbcan.2017.03.010
 
Language:English
Typology:1.02 - Review Article
Organization:Logo NIB - National Institute of Biology
Abstract:Acute myeloid leukemia and acute lymphoblastic leukemia cells hijack hematopoietic stem cell (HSC) niches in the bone marrow and become leukemic stem cells (LSCs) at the expense of normal HSCs. LSCs are quiescent and resistant to chemotherapy and can cause relapse of the disease. HSCs in niches are needed to generate blood cell precursors that are committed to unilineage differentiation and eventually production of mature blood cells, including red blood cells, megakaryocytes, myeloid cells and lymphocytes. Thus far, three types of HSC niches are recognized: endosteal, reticular and perivascular niches. However, we argue here that there is only one type of HSC niche, which consists of a periarteriolar compartment and a perisinusoidal compartment. In the periarteriolar compartment, hypoxia and low levels of reactive oxygen species preserve the HSC pool. In the perisinusoidal compartment, hypoxia in combination with higher levels of reactive oxygen species enables proliferation of progenitor cells and their mobilization into the circulation. Because HSC niches offer protection to LSCs against chemotherapy, we review novel therapeutic strategies to inhibit homing of LSCs in niches for the prevention of dedifferentiation of leukemic cells into LSCs and to stimulate migration of leukemic cells out of niches. These strategies enhance differentiation and proliferation and thus sensitize leukemic cells to chemotherapy. Finally, we list clinical trials of therapies that tackle LSCs in HSC niches to circumvent their protection against chemotherapy.
Keywords:hematopoietic stem cell niche, hijacking, leukemic stem cells, bone marrow, therapy resistance, leukemia
Publication status:Published
Publication version:Version of Record
Publication date:01.08.2017
Year of publishing:2017
Number of pages:str. 183-198
Numbering:Vol. 1868, iss. 1
PID:20.500.12556/DiRROS-20138 New window
UDC:61
ISSN on article:0304-419X
DOI:10.1016/j.bbcan.2017.03.010 New window
COBISS.SI-ID:40483077 New window
Publication date in DiRROS:06.08.2024
Views:275
Downloads:226
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Biochimica et biophysica acta CR : Reviews on cancer
Shortened title:Biochim. biophys. acta CR, Rev. cancer
Publisher:Elsevier Scientific Publ. Co.
ISSN:0304-419X
COBISS.SI-ID:14631975 New window

Document is financed by a project

Funder:Other - Other funder or multiple funders
Funding programme:René Vogels travel grant

Funder:Other - Other funder or multiple funders
Funding programme:JoKolk scholarship

Funder:Other - Other funder or multiple funders
Funding programme:the Dutch Cancer Society grant
Project number:V

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:medicinske znanosti, levkemija, zdravljenje, terapevtske strategije


Back